Label (71610 0927 53)
Doxazosin Tablet
Product Images NDC 71610-927
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 71610-927). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Aphena (Aphena)
Chemical Structure (Doxazosin 01)
Table 3 (Doxazosin 02)
This is a summary of effectiveness data from placebo-controlled trials evaluating the impact of Cardura on maximum flow rate and symptom scores in patients with BPH. The trials involved different dosage titration methods and assessed changes from baseline to endpoint. Cardura showed improvement in maximum flow rate and symptoms compared to placebo, based on AUA questionnaire and Modified Boyarsky Questionnaire results. Study results suggest that Cardura, particularly at higher doses, could be beneficial in managing BPH symptoms.*
Figure 1 (Doxazosin 03)
This is a comparison table displaying the mean change in total symptom score and mean increase in maximum urinary flow rate from baseline across different durations of treatment in weeks. It includes results for Placebo and Doxazosin, with statistical significance indicated. The text mentions that Doxazosin was titrated up to a maximum of 8 mg.*
Logo (Doxazosin 04)
This is a description of a product labeled as "GREENSTONE® BRAND" distributed by Greenstone LLC based in Peapack, NJ 07977.*
Logo (Doxazosin 04a)
This is a description of a pharmaceutical product named Greenstone® Brand, distributed by Greenstone LLC based in Peapack, NJ 07977.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
